Alcon Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALCON
ALCON has fifty-eight approved drugs.
There are forty-six US patents protecting ALCON drugs. There is one tentative approval on ALCON drugs.
There are two hundred and forty-one patent family members on ALCON drugs in thirty-three countries and eighty-eight supplementary protection certificates in fifteen countries.
Summary for Alcon
| International Patents: | 241 |
| US Patents: | 46 |
| Tradenames: | 49 |
| Ingredients: | 41 |
| NDAs: | 58 |
| Patent Litigation for Alcon: | See patent lawsuits for Alcon |
| PTAB Cases with Alcon as patent owner: | See PTAB cases with Alcon as patent owner |
Drugs and US Patents for Alcon
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | 9,993,470 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 206276-001 | Jan 30, 2015 | OTC | Yes | Yes | 8,791,154 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Alcon | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 207926-001 | Jan 15, 2015 | AT | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | 11,219,596 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Alcon Labs Inc | CYCLOMYDRIL | cyclopentolate hydrochloride; phenylephrine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084300-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Alcon Labs Inc | TRYPTYR | acoltremon | SOLUTION/DROPS;OPHTHALMIC | 217370-001 | May 28, 2025 | RX | Yes | Yes | 9,095,609 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alcon
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | 9,096,569 | ⤷ Start Trial |
| Alcon Pharms Ltd | TRAVATAN | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021257-001 | Mar 16, 2001 | 5,510,383 | ⤷ Start Trial |
| Alcon Labs Inc | PATADAY TWICE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020688-001 | Dec 18, 1996 | 4,871,865 | ⤷ Start Trial |
| Alcon Labs Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | 8,450,344 | ⤷ Start Trial |
| Alcon Labs Inc | SIMBRINZA | brimonidine tartrate; brinzolamide | SUSPENSION/DROPS;OPHTHALMIC | 204251-001 | Apr 19, 2013 | 6,316,441 | ⤷ Start Trial |
| Alcon Pharms Ltd | TRAVATAN | travoprost | SOLUTION/DROPS;OPHTHALMIC | 021257-001 | Mar 16, 2001 | 5,889,052 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ALCON drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.00% | ➤ Subscribe | 2008-11-28 |
| ➤ Subscribe | Ophthalmic Solution | 0.03% | ➤ Subscribe | 2004-12-23 |
International Patents for Alcon Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3045164 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2013166385 | ⤷ Start Trial |
| New Zealand | 742004 | ⤷ Start Trial |
| Japan | 2016183198 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2010127330 | ⤷ Start Trial |
| Spain | 2553827 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alcon Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2957286 | 132019000000021 | Italy | ⤷ Start Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM E QUALSIASI SUO SALE O DERIVATO(VELTASSA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1179, 20170721 |
| 1581193 | SPC/GB12/047 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727 |
| 1280520 | C300722 | Netherlands | ⤷ Start Trial | PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720 |
| 3043773 | SPC/GB21/077 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: MOMETASONE OR A SALT THEREOF AND OLOPATADINE OR A SALT THEREOF; REGISTERED: AT 140638 20210426; UK PL 25258/0331 - 0001 20210511 |
| 1631293 | 2014/041 | Ireland | ⤷ Start Trial | PRODUCT NAME: BRIMONIDINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTRATION NO/DATE: EU/1/13/904 20140221 |
| 3053913 | SPC/GB20/019 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: NETARSUDIL; REGISTERED: UK EU/1/19/1400(NI) 20191121; UK PLGB 16058/003 20191121 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
